Geron | GERN - Pre Tax Profit

Stock Price
1.69
Daily Change
0.04 2.12%
Monthly
-3.16%
Yearly
28.63%
Q2 Forecast
1.55

Geron reported $-31.14M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Amgen USD 1.51B 2.41B Dec/2025
Bio Techne USD 50.78M 34.21M Dec/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Exelixis USD 267.69M 15M Mar/2026
Genmab DKK 55M 427M Dec/2025
Geron USD -31.14M 12.72M Dec/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
Incyte USD 343.6M 46.34M Mar/2026
MacroGenics USD -14.93M 31.75M Dec/2025
Novartis USD 3.84B 802M Mar/2026
Novavax USD 17.9M 220.94M Dec/2025